Premium
Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, e... Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material. Show more
Introduces 2025 full year revenue guidance of $180 million to $200 million, a 17% increase in revenue growth over 2024, and core adjusted earnings per diluted share of $6.00 to $6.25 Twelve...
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will present at the Stifel 2024 Healthcare...
WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.62 | 3.09904973889 | 116.81 | 124.0296 | 113.39 | 111666 | 118.45221742 | CS |
| 4 | 9.71 | 8.7698699422 | 110.72 | 127.86 | 109.525 | 109410 | 119.4005244 | CS |
| 12 | 20.57 | 20.5988383737 | 99.86 | 129.9 | 96.96 | 110088 | 114.20248961 | CS |
| 26 | 40.43 | 50.5375 | 80 | 129.9 | 77.53 | 116090 | 105.57976253 | CS |
| 52 | 53.06 | 78.7590915838 | 67.37 | 129.9 | 67.36 | 132984 | 89.45229671 | CS |
| 156 | -19.46 | -13.9109300164 | 139.89 | 164.84 | 49.24 | 134332 | 85.80525166 | CS |
| 260 | 13.88 | 13.0267480056 | 106.55 | 219.75 | 49.24 | 210544 | 105.65221709 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
